NCT01470729View on ClinicalTrials.gov

Biomarkers in Autosomal Dominant Cerebellar Ataxia

CompletedOBSERVATIONAL
Enrollment

102

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Spinocerebellar Ataxia Type 1Spinocerebellar Ataxia Type 2Spinocerebellar Ataxia, Autosomal Recessive 3Episodic Ataxia, Type 7
Interventions
OTHER

metabolic and imaging biomarkers in SCA1,2,3 and 7 patients

MRI, a bone mineral density and a resting metabolic rate assessments, as well as donating fasted blood samples

Trial Locations (1)

75013

Groupe Hospitalier Pitié Salpêtrière, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT01470729 - Biomarkers in Autosomal Dominant Cerebellar Ataxia | Biotech Hunter | Biotech Hunter